Contribution of 68Ga-PSMA PET/CT to targeting volume delineation of prostate cancer treated with conformal radiation therapy: Which SUV threshold is appropriate?
Authors
Abstract:
Introduction: Prostate-specific membrane antigen (PSMA) has been demonstrated as a promising tool for specific imaging of prostate cancer (PCa) via positron emission tomography-computed tomography (PET/CT) scanning. Radiation treatment planning (RTP) based on 68Ga-PSMA PET/CT scanning can also lead to some decision modifications. The specific goal of this comparative study is to show how 68Ga-PSMA PET/CT images can influence the target volume delineation (TVD) and normal tissue radiation dose for PCa RTP, and to compare gross tumor volumes (GTVs) delineated using various strategies for 68Ga-PSMA PET-based image segmentation techniques. Methods: This study consisted of eleven 68Ga-PSMA PET/CT images related to patients affected with locally advanced PCa. Four strategies also included manual segmentation techniques, a 2.5 standardized uptake value (SUV) cutoff (SUV=2.5), as well as a fixed threshold of 40% and 50% of the maximum signal intensity (SUV=%40 SUVmax and SUV=%50 SUVmax) for 68Ga-PSMA PET-based segmentation techniques to delineate GTVPET. Two treatment planning were accordingly generated for each patient based on manual GTVPET and CT-only. Results: The GTV was statistically and significantly smaller for PET/CT-derived volumes (9.39 vs. 77.98 cm3 for CT alone) (p<0.002). There was no significant difference in volumes of GTV2.5 and GTV40% with GTVman (p=0.11) although we observed a significant difference in volumes of GTV50% with GTVman (p=0.02). Mean bladder dose (MBD), V50 of rectum, and mean femoral dose (MFD) for PET/CT plans were significantly lower than CT-only (22.36 vs. 46.55 Gy; p=0.004), (33% vs. 67.82%; p=0.000), and (28.01 vs. 37.12Gy; p=0.013); respectively. Conclusion: The contribution of hybrid modalities of PSMA-PET/CT can be useful for detailed target volume planning and reduce radiation exposure to organs at risk. Using molecular images in RTP also demonstrates the biological volume of GTV so that it will not be left out of the field to cause recurrent tumor.
similar resources
Optimization of clinical target volume delineation using magnetic resonance spectroscopic imaging (MRSI) in 3D conformal radiotherapy of prostate cancer
Background: For the purpose of individual clinical target volume assessment in radiotherapy of prostate cancer, MRSI was used as a molecular imaging modality with MRI and CT images. Materials and Methods: The images of 20 prostate cancer patients were used in this study. The MR and MRSI images were registered with CT ones using non-rigid registration technique. The CT based planning (BP), CT/MR...
full textComparison of Radiobiological Models for Radiation Therapy Plans of Prostate Cancer: Three-dimensional Conformal versus Intensity Modulated Radiation Therapy
Purpose: In the current study, using different radiobiological models, tumor control probability (TCP) and normal tissue complication probability (NTCP) of radiotherapy plans were calculated for three-dimensional conformal radiation therapy (3D-CRT) and intensity modulated radiation therapy (IMRT) of prostate cancer.Methods and Materials: 10 prostate plans were randomly selected among patients ...
full textDirect comparison of 99mTc-PSMA SPECT/CT and 68Ga-PSMA PET/CT in patients with prostate cancer
Objective(s): 99mTc-PSMA SPECT/CT is a cost effective alternative for 68Ga-PSMA PET/CT. The aim of this study was to directly compare these two techniques in patients with prostate cancer. Methods: 28 man with prostate cancer were studied using 99mTc-PSMA SPECT/CT and 68Ga-PSMA PET/CT in a shor...
full textThe Role of MRSI in Target Volume Definition for Radiation Therapy of Prostate Cancer
Introduction: Recently, magnetic resonance spectroscopic imaging (MRSI), as a functional imaging method, has been used for clinical target volume definition. In this study, we used this method to define the target volume in prostate radiotherapy. Material and Method: In this study, we used images of 20 prostate cancer cases. MRSI and MRI images were fused with CT images. Then, treatment plannin...
full textDelineating biochemical failure with 68Ga-PSMA-PET following definitive external beam radiation treatment for prostate cancer.
BACKGROUND AND PURPOSE We investigated the role of 68Ga-PSMA-PET (PSMA) to determine the location of disease recurrence in those with a rising PSA following definitive external beam radiation treatment (EBRT). MATERIALS AND METHODS 538men were treated with image guided EBRT to a dose of 78 or 82Gy between 2007 and 2014. Patients at least 24months post EBRT with biochemical failure (nadir+2) u...
full textAutomatic Segmentation of the Gross Tumor Volume in Prostate Carcinoma Using Fuzzy Clustering in Gallium-68 PSMA PET/CT Scan
Introduction: Modern radiotherapy (RT) techniques allow a highly precise deposition of the radiation dose in tumor. So, high conformal tumor doses can be reached while sparing critical organs at risk. Materials and Methods: This study was conducted in three phases. In the first phase; Fourteen patients with primary or recurrent prostate cancer receive Gallium-...
full textMy Resources
Journal title
volume 28 issue 2
pages 20- 29
publication date 2020-07-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023